The Oncology Institute, Inc.
TOI · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $23,188 | $150,447 | $120,109 | $645,748 |
| - Cash | $49,669 | $33,488 | $14,010 | $114,299 |
| + Debt | $123,152 | $119,675 | $108,179 | $183 |
| Enterprise Value | $96,671 | $236,634 | $214,278 | $531,632 |
| Revenue | $393,412 | $324,239 | $252,483 | $203,003 |
| % Growth | 21.3% | 28.4% | 24.4% | – |
| Gross Profit | $53,997 | $59,573 | $52,093 | $40,848 |
| % Margin | 13.7% | 18.4% | 20.6% | 20.1% |
| EBITDA | -$53,831 | -$54,278 | -$67,596 | -$42,041 |
| % Margin | -13.7% | -16.7% | -26.8% | -20.7% |
| Net Income | -$64,663 | -$83,068 | $152 | -$10,927 |
| % Margin | -16.4% | -25.6% | 0.1% | -5.4% |
| EPS Diluted | -0.71 | -0.92 | -0.21 | -0.16 |
| % Growth | 22.8% | -338.1% | -31.2% | – |
| Operating Cash Flow | -$26,538 | -$36,315 | -$61,756 | -$32,680 |
| Capital Expenditures | -$3,789 | -$4,567 | -$5,529 | -$3,047 |
| Free Cash Flow | -$30,327 | -$40,882 | -$67,285 | -$35,727 |